Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference
OptiNose, Inc. (NASDAQ:OPTN) Just Reported, And Analysts Assigned A US$3.50 Price Target [Yahoo! Finance]
OptiNose, Inc. (NASDAQ: OPTN) had its price target lowered by analysts at Piper Sandler from $3.00 to $1.00. They now have an "overweight" rating on the stock.
OptiNose, Inc. (NASDAQ: OPTN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
OptiNose Inc (OPTN) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Revised Guidance [Yahoo! Finance]